vector-borne disease
vector-borne disease
Explore linked clinical trials. Standard reference: MONDO:0100120308 results · Page 1 of 13
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Positron Emission Tomography and Organ-Specific Changes in Participants Co-Enrolled in NIH Studies of Plasmodium Vivax Controlled Human Malaria Infection | Infections, Mosquito-Borne Diseases, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Not applicable | 2026-10-09 | NCT07859800 | |
| Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders | Bacterial Infections and Mycoses, Borrelia infectious disease, Hemic and Lymphatic Diseases, Infections, Picornaviridae infectious disease, RNA Virus Infections, bacterial infectious disease, bone marrow disorder, foot and mouth disease, gram-negative bacterial infections, hematologic disorder, mosaic trisomy 8, myelodysplastic syndrome, non-human animal disease, relapsing fever, spirochaetales infections, tick-borne infectious disease, vector-borne disease, viral infectious disease | Recruiting | Not stated | 2026-10-09 | NCT07683104 | |
| Southeast Asia Dose Optimization of Tafenoquine | Disease Attributes, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Plasmodium vivax malaria, Recurrence, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 4 | 2026-10-09 | NCT04704999 | |
| Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Not stated | 2026-10-08 | NCT02471378 | |
| Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali | Body Temperature Changes, Fever, Infections, Mosquito-Borne Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Not stated | 2026-10-08 | NCT01168271 | |
| Evaluation, Treatment, and Follow-up of Patients With Lyme Disease | Bacterial Infections and Mycoses, Borrelia infectious disease, Infections, Lyme disease, bacterial infectious disease, gram-negative bacterial infections, spirochaetales infections, tick-borne infectious disease, vector-borne disease | Recruiting | Not stated | 2026-10-08 | NCT00028080 | |
| Better Options for Lymphatic Filariasis Treatment | Hemic and Lymphatic Diseases, Infections, Mosquito-Borne Diseases, Nematoda infectious disease, Rhabditida infectious disease, Secernentea Infections, Skin and Connective Tissue Diseases, Spirurida Infections, filarial elephantiasis, filariasis, helminthiasis, lymphatic system disorder, lymphedema, mite infestation, parasitic ectoparasitic infectious disease, parasitic infectious disease, parasitic skin disorder, scabies, skin disorder, skin disorder caused by infection, strongyloidiasis, vector-borne disease | Recruiting | Phase 3 | 2026-10-07 | NCT07159373 | |
| Immersive Technology Headsets to Reduce Procedural Pain and Anxiety: Feasibility and Effects in Cutaneous Leishmaniasis Patients in Pakistan | Euglenozoa Infections, Infections, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin and Connective Tissue Diseases, anxiety, anxiety disorder, cutaneous leishmaniasis, leishmaniasis, parasitic infectious disease, parasitic skin disorder, protozoa infectious disease, psychiatric disorder, skin disorder, skin disorder caused by infection, vector-borne disease | Not yet recruiting | Not applicable | 2026-10-05 | NCT07858357 | |
| First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy Adults | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 1 | 2026-10-05 | NCT07646353 | |
| RVF and Other Emerging Infectious Diseases in East and Central Africa | Bunyaviridae infectious disease, Communicable Diseases, Emerging, Digestive System Diseases, Disease Attributes, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Rift valley fever, arbovirus infection, hepatitis, hepatitis, non-human animal, hepatitis, viral, animal, infectious disease, liver disorder, non-human animal disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Not stated | 2026-10-05 | NCT05139524 | |
| The Precision Mito- Mito Map COMPASS Study | Bacterial Infections and Mycoses, Borrelia infectious disease, Chronic Disease, Disease Attributes, Fatigue, Infections, Lyme disease, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, Signs and Symptoms, autonomic nervous system disorder, bacterial infectious disease, fibromyalgia, gram-negative bacterial infections, inborn mitochondrial metabolism disorder, metabolic disease, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, orthostatic intolerance, post-treatment Lyme disease syndrome, primary dysautonomia, rheumatic disorder, spirochaetales infections, tick-borne infectious disease, vector-borne disease | Not yet recruiting | Not stated | 2026-10-02 | NCT07856121 | |
| Effectiveness of an Intervention Combining Adapted Physical Activity and Therapeutic Education in Patients With Chronic Symptoms Attributed to Lyme Borreliosis. | Bacterial Infections and Mycoses, Borrelia infectious disease, Central Nervous System Bacterial Infections, Infections, Lyme Neuroborreliosis, Lyme disease, bacterial infectious disease, central nervous system disorder, central nervous system infectious disorder, gram-negative bacterial infections, nervous system disorder, spirochaetales infections, tick-borne infectious disease, vector-borne disease | Recruiting | Not applicable | 2026-10-02 | NCT05641116 | |
| Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Infections, Mosquito-Borne Diseases, anemia, beta thalassemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, malaria, parasitic infectious disease, protozoa infectious disease, sickle cell disease, thalassemia, vector-borne disease | Recruiting | Not stated | 2026-10-02 | NCT03937817 | |
| Diagnosis and Treatment of Leishmania Infections | Euglenozoa Infections, Infections, Skin and Connective Tissue Diseases, cutaneous leishmaniasis, leishmaniasis, mucocutaneous leishmaniasis, parasitic infectious disease, parasitic skin disorder, protozoa infectious disease, skin disorder, skin disorder caused by infection, vector-borne disease, visceral leishmaniasis | Recruiting | Not stated | 2026-10-02 | NCT00344188 | |
| Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection | Infections, Mosquito-Borne Diseases, Trematode Infections, helminthiasis, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Not stated | 2026-10-02 | NCT00001645 | |
| An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older | Infections, Mosquito-Borne Diseases, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 3 | 2026-10-01 | NCT06666491 | |
| A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children. | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Active, not recruiting | Phase 3 | 2026-09-30 | NCT07003984 | |
| Evaluation of IXCHIQ® Vaccine Immunogenicity | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Not yet recruiting | Phase 2 | 2026-09-29 | NCT07846293 | |
| Testing of a New Rapid Antigen Test for Plague in Ituri, Democratic Republic of the Congo. | Bacterial Infections and Mycoses, Enterobacteriaceae Infections, Infections, Yersinia infectious disease, bacterial infectious disease, gram-negative bacterial infections, plague, vector-borne disease | Not yet recruiting | Not stated | 2026-09-29 | NCT07174648 | |
| Infant Malaria Vaccine Schedule Optimization | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Active, not recruiting | Phase 2 | 2026-09-29 | NCT06879327 | |
| Real-world Effectiveness, Safety & Immunogenicity of Chikungunya Vaccination: Ambispective Study in Reunion & French Guiana | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Recruiting | Phase 4 | 2026-09-28 | NCT06928753 | |
| Adaptive Dengue Antiviral Platform Trial | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 2 | 2026-09-28 | NCT06551844 | |
| Ethiopian Antimalarial Therapeutic Efficacy Study 2026 | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Not stated | 2026-09-25 | NCT07840898 | |
| Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-50 Years | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 1 | 2026-09-25 | NCT07831226 | |
| Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 1 | 2026-09-25 | NCT07706686 |